Delivery Order SPE2DB22D2211-SPE2DB25FSFAW
- Not listed
- The Defense Logistics Agency awarded a $3,471.54 firm fixed price delivery order to AmerisourceBergen Drug Corp for VYEPTI 100 mg/ml vials, with an ultimate completion date of September 4, 2025. This non-set-aside contract represents a single delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VYEPTI 100 mg/ml vials valued at $1,157.18 under a firm fixed price contract. The award, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a competitively awarded, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,471.54 firm fixed-price delivery order on September 5, 2025, for VYEPTI 100 mg/mL vial medication, with completion targeted for September 26, 2025. This is a non-set-aside competitive award issued to the Conshohocken, Pennsylvania-based pharmaceutical distributor, one of the federal government's major medical supply vendors. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency awarded a $4,628.72 delivery order to AmerisourceBergen Drug Corp for VYEPTI (eptinezumab) 100 mg/ml vials, with performance at the contractor's Conshohocken, Pennsylvania location and an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a $4,628.72 firm fixed price delivery order to AmerisourceBergen Drug Corp for VYEPTI 100 mg/mL vials, with an ultimate completion date of August 8, 2025. This non-set-aside contract was competitively awarded on July 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VYEPTI 100 mg/mL vials valued at $3,471.54 on August 12, 2025, with completion targeted for September 3, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The award will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. VYEPTI (eptinezumab) is a monoclonal antibody used for migraine prevention,...
- The Defense Logistics Agency awarded a $69,431 firm fixed price delivery order to AmerisourceBergen Drug Corp for VYEPTI 100 mg/ml vials, with an ultimate completion date of October 6, 2025. This is a non-set-aside, competitively awarded contract for pharmaceutical supply. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and operates as a major pharmaceutical distributor providing comprehensive medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,628.72 to AmerisourceBergen Drug Corp for VYEPTI 100 mg/ml vials, with an ultimate completion date of August 18, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through an open procurement process. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $9,257.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of VYEPTI 100 mg/ml vial medication. The contract, with an ultimate completion date of September 30, 2025, is non-set-aside and competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location in the same city. This delivery...
- The Defense Logistics Agency awarded a $5,785.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for VYEPTI 100 mg/mL vial on September 11, 2025, with an ultimate completion date of October 2, 2025. This delivery order is not set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is fulfilling this order under its...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSFAWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,628.72 to AmerisourceBergen Drug Corp for VYEPTI 100 mg/mL vial on September 16, 2025, with an ultimate completion date of October 7, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical and healthcare solutions provider, regularly fulfills federal medical procurement requirements through this expansive IDC vehicle. The company supplies a broad portfolio of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. VYEPTI is indicated for the prevention of episodic migraine in adults and represents the type of specialty medication within the company's extensive therapeutic domain coverage. The DLA Troop Support Medical contract demonstrates AmerisourceBergen's established capability to meet federal procurement standards through open competition and positions the company as a key vendor for military and veteran healthcare supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 9/16/25 |